GPS đã phải chịu đòn chí mạng sau khi sụp đổ: Liệu chính sách mới của Binance có thể sắp xếp lại thị trường?

Isabl Inc.

company

About

Isabl integrates the whole genome and transcriptome to inform cancer care.

Details

Last Funding Type
Seed
Last Funding Money Raised
$3M
Industries
Biotechnology,Health Diagnostics,Hospital,Medical
Founded date
Jan 1, 2020
Number Of Employee
1 - 10
Operating Status
Active

Isabl specializes in the fields of whole-genome cancer diagnostics. The company is currently looking to partner with oncology centers nationwide to showcase the value of using whole-genome sequencing in clinical cancer care.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$3M
Isabl Inc. has raised a total of $3M in funding over 2 rounds. Their latest funding was raised on May 18, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 18, 2022 Seed $3M 4 Two Sigma Ventures Detail
Jun 1, 2020 Series Unknown 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
5
Isabl Inc. is funded by 5 investors. Two Sigma Ventures and Milad Alucozai are the most recent investors.
Investor Name Lead Investor Funding Round
Two Sigma Ventures Yes Seed
Milad Alucozai Seed
Sand Hill Angels Seed
Y Combinator Seed
Bossanova Investimentos Series Unknown

Employee Profiles

Number of Employee Profiles
3
Isabl Inc. has 3 current employee profiles, including Executive Andrew Kung
Executive
Executive
Executive